Clinical Trials Directory

Trials / Terminated

TerminatedNCT01221961

Masimo Radical-7 Monitor a Useful Adjuvant During Major Spine Surgery

A Study to Determine the Agreement Between Masimo Monitor and Standard of Care

Status
Terminated
Phase
Study type
Observational
Enrollment
62 (actual)
Sponsor
Cedars-Sinai Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This is a study designed to compare the agreement of hemoglobin (Hb) measurements, documented at specific time points (the time a blood sample was obtained by the standard clinical care after physician/nurse orders it and, during that same time, the Hb value recorded by the Masimo Radical-7 monitor); recorded several times throughout patient's major spine surgery procedure (depending on how many times the physician/nurse orders the Hb value to be tested), between the standard clinical practice {intermittent measure of Hb \[Cedar Sinai Medical Center (CSMC) Lab and outside lab) and Masimo radical-7 device (continuous, non-invasive Hb level measurements)\*.

Detailed description

\*See whether or not the hemoglobin values recorded at the same time matches between the standard clinical practice (CSMC Lab and outside Lab) and the Masimo device

Conditions

Interventions

TypeNameDescription
DEVICEMasimo Radical-7The Masimo device will be placed on one finger of the patient. To see whether or not the hemoglobin values recorded at the same time matches between the standard clinical practice (CSMC Lab and outside Lab) and the Masimo device

Timeline

Start date
2010-10-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2010-10-18
Last updated
2013-11-15

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01221961. Inclusion in this directory is not an endorsement.